IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Emmaus Life Sciences Inc (EMMA)

CUSIP: 29137T101 | NYSE | 2 institutional holders

Quarters

Q3 2020Q3 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2020

Diametric Capital, LP57,034
0.0% of portfolio›$55
StyleTurnoverLocationFiled
Diametric Capital, LP
57,034$550.0%CoreVery HighBoston, MA2020-11-13